Glenmark Pharma gets tentative USFDA nod for generic anti-diabetes tablets

Glenmark Pharmaceuticals on Wednesday said it has received tentative approval from the US health regulator for its generic Dapagliflozin and Saxagliptin anti-diabetes tablets.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news